Selective agonists of the δ-opioid receptor, KNT-127 and SNC80, act differentially on extinction learning of contextual fear memory in mice

Neuropharmacology. 2019 Dec 1:160:107792. doi: 10.1016/j.neuropharm.2019.107792. Epub 2019 Sep 22.

Abstract

We reported previously that KNT-127 and SNC80, selective agonists of the δ-opioid receptor (DOP), had potent anxiolytic-like effects in rodents. In this study, we evaluated whether KNT-127 and SNC80 influence extinction learning of contextual fear memory in the mice fear conditioning test. On day 1, the mice were contextually conditioned with eight trials (footshock; 0.8 mA, 1-s, 30-s interval). On day 2, the mice were re-exposed to the conditioning chamber for 6 min as an extinction training (re-exposure 1), 30 min after drug administration. On day 3, the mice were re-exposed to the chamber for 6 min as a memory testing (re-exposure 2). In re-exposure 1, KNT-127 and SNC80 significantly reduced the freezing behavior. In re-exposure 2, KNT-127, but not SNC80, significantly reduced the freezing behavior. These effects of KNT-127 were antagonized by the DOP antagonist naltrindole. KNT-127 increased the phosphorylated ERK levels in the amygdala and hippocampus, but not in the medial prefrontal cortex 60 min after re-exposure 1. These results suggest that both KNT-127 and SNC80 produced anxiolytic-like effects in the re-exposure 1, however, in contrast to SNC80, KNT-127 facilitated extinction learning of contextual fear memory in the re-exposure 2. Further, we suggest that amygdaloid and hippocampal MAPK/ERK signaling serves as the key mediators of the enhancement of extinction learning of contextual fear memory via DOPs after KNT-127 treatment. We propose that, although the DOP agonists KNT-127 and SNC80 produce anxiolytic-like effects on contextually conditioned fear, these drugs have different mechanisms on extinction learning of contextual fear memory.

Keywords: Anxiety; Extinction learning; Fear memory; δ-opioid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anxiety / drug therapy
  • Behavior, Animal / drug effects
  • Benzamides / administration & dosage
  • Benzamides / pharmacology*
  • Conditioning, Psychological / drug effects
  • Extinction, Psychological / drug effects*
  • Fear / drug effects*
  • Learning / drug effects
  • Male
  • Memory / drug effects*
  • Mice
  • Morphinans / administration & dosage
  • Morphinans / pharmacology*
  • Motor Activity / drug effects
  • Naltrexone / analogs & derivatives
  • Naltrexone / antagonists & inhibitors
  • Piperazines / administration & dosage
  • Piperazines / pharmacology*
  • Receptors, Opioid, delta / agonists*
  • Receptors, Opioid, delta / metabolism

Substances

  • Anti-Anxiety Agents
  • Benzamides
  • DOR-1 protein, mouse
  • KNT 127
  • Morphinans
  • Piperazines
  • Receptors, Opioid, delta
  • 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
  • Naltrexone
  • naltrindole